Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices 32459 

Aldrich Research Biochemicals, Inc., 1– 

3 Strathmore Road, Natick, 

Massachusetts 01760–2447, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

Aminorex (1585) ........................... I 

Alpha-ethyltryptamine (7249) ....... I 

Lysergic acid diethylamide (7315) I 

Tetrahydrocannabinols (7370) ..... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4- 

Methylenedioxymethamphetamine (MDMA) (7405).

I 

Psilocybin (7437) .......................... I 

5-Methoxy-N,Ndiisopropyltryptamine (7439).I 

1-[1-(2- 

Thienyl)cyclohexyl]piperidine 

(TCP) (7470).

I 

N-Benzylpiperazine (BZP) (7493) I 

Heroin (9200) ............................... I 

Normorphine (9313) ..................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Nabilone (7379) ............................ II 

1-Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Ecgonine (9180) ........................... II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ...................... II 

Meperidine (9230) ........................ II 

Metazocine (9240) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Remifentanil (9739) ...................... II 

Carfentanil (9743) ......................... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

reference standards. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Sigma Aldrich Research Biochemicals, 

Inc., to manufacture the listed basic 

classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated Sigma 

Aldrich Research Biochemicals, Inc., to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed. 

Dated: May 22, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–12832 Filed 5–29–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration; 

Mallinckrodt, LLC. 

By Notice dated February 8, 2013, and 

published in the Federal Register on 

February 21, 2013, 78 FR 12102, 

Mallinckrodt, LLC., 3600 North Second 

Street, St. Louis, Missouri 63147, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Tetrahydrocannabinols (7370) ..... I 

Codeine-N-oxide (9053) ............... I 

Dihydromorphine (9145) ............... I 

Difenoxin (9168) ........................... I 

Morphine-N-oxide (9307) ............. I 

Normorphine (9313) ..................... I 

Norlevorphanol (9634) .................. I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Nabilone (7379) ............................ II 

4-Anilino-N-phenethyl-4-piperidine 

(8333).

II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Levorphanol (9220) ...................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk (non— 

dosage forms) (9273).

II 

Morphine (9300) ........................... II 

Drug Schedule 

Oripavine (9330) ........................... II 

Thebaine (9333) ........................... II 

Opium tincture (9630) .................. II 

Opium, powdered (9639) ............. II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Alfentanil (9737) ........................... II 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................ II 

The firm plans to manufacture the 

listed controlled substances for internal 

use and for sale to other companies. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Mallinckrodt, LLC., to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Mallinckrodt, LLC., to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed. 

Dated: May 22, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–12831 Filed 5–29–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Office of the Secretary 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; Reporting 

and Performance Standards for 

Workforce Investment Act Indian and 

Native American Programs 

ACTION: Notice. 

SUMMARY: On May 31, 2013, the 

Department of Labor (DOL) will submit 

the Employment and Training (ETA) 

sponsored information collection 

request (ICR) revision titled, ‘‘Reporting 

and Performance Standards for 

Workforce Investment Act Indian and 

Native American Programs,’’ to the 

Office of Management and Budget 


TKELLEY on DSK3SPTVN1PROD with NOTICES
32460 Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices 

(OMB) for review and approval for use 

in accordance with the Paperwork 

Reduction Act (PRA) of 1995 (44 U.S.C. 

3501 et seq.). 

DATES: Submit comments on or before 

July 1, 2013. 

ADDRESSES: A copy of this ICR with 

applicable supporting documentation; 

including a description of the likely 

respondents, proposed frequency of 

response, and estimated total burden 

may be obtained free of charge from the 

RegInfo.gov Web site at http:// 

www.reginfo.gov/public/do/ 

PRAViewICR?ref_nbr=201212-1205-006 

(this link will only become active on 

June 1, 2013) or by contacting Michel 

Smyth by telephone at 202–693–4129 

(this is not a toll-free number) or 

sending an email to 

DOL_PRA_PUBLIC@dol.gov. 

Submit comments about this request 

to the Office of Information and 

Regulatory Affairs, Attn: OMB Desk 

Officer for DOL–ETA, Office of 

Management and Budget, Room 10235, 

725 17th Street, NW., Washington, DC 

20503, Fax: 202–395–6881 (this is not a 

toll-free number), email: 

OIRA_submission@omb.eop.gov. 

FOR FURTHER INFORMATION CONTACT: 

Contact Michel Smyth by telephone at 

202–693–4129 (this is not a toll-free 

number) or by email at 

DOL_PRA_PUBLIC@dol.gov. 

Authority: 44 U.S.C. 3507(a)(1)(D). 

SUPPLEMENTARY INFORMATION: This ICR 

covers the recordkeeping and reporting 

system for the Indian and Native 

Americans funded grants and has three 

constituent information collections: (1) 

A quarterly Comprehensive Services 

Program report (Form ETA–9084), (2) a 

Standardized Participant Information 

Record, and (3) a quarterly 

Supplemental Youth Services Program 

Report (Form ETA–9085). These three 

information collections are the basis of 

the performance standards system for 

Workforce Investment Act section 166 

grantees. 

The ETA is revising this ICR in the 

following manner. Form ETA 9084 will 

now capture the number of eligible 

veterans and spouses served (with the 

addition of two data fields). The DOL 

notes that Form ETA–9085 has already 

been recording this information and will 

not be changed. In addition, Form ETA– 

9085 information will now be collected 

on the number of eligible youth between 

the ages of 14–21 years, rather than ages 

14–24, which was allowed under the 

American Reinvestment and Recovery 

Act of 2009 (ARRA). Form ETA–9085 

adds a credential attainment measure. 

Finally, Form-ETA 9085 data will revert 

to being collected quarterly, rather than 

monthly, as was the case prior to ARRA 

requirements. For additional substantive 

information about this ICR, see the 

related notice published in the Federal 

Register on March 28, 2013 (78 FR 

19018). 

This information collection is subject 

to the PRA. A Federal agency generally 

cannot conduct or sponsor a collection 

of information, and the public is 

generally not required to respond to an 

information collection, unless it is 

approved by the OMB under the PRA 

and displays a currently valid OMB 

Control Number. In addition, 

notwithstanding any other provisions of 

law, no person shall generally be subject 

to penalty for failing to comply with a 

collection of information that does not 

display a valid Control Number. See 5 

CFR 1320.5(a) and 1320.6. The DOL 

obtains OMB approval for this 

information collection under Control 

Number 1205–0422. The current 

approval is scheduled to expire on May 

31, 2013; however, it should be noted 

that existing information collection 

requirements submitted to the OMB 

receive a month-to-month extension 

while they undergo review. New 

information collection requirements 

will only take effect upon OMB 

approval. 

Interested parties are encouraged to 

send comments to the OMB, Office of 

Information and Regulatory Affairs at 

the address shown in the ADDRESSES 

section by July 1, 2013. In order to help 

ensure appropriate consideration, 

comments should mention OMB Control 

Number 1205–0422. The OMB is 

particularly interested in comments 

that: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Agency: DOL-Employment and 

Training Administration. 

Title of Collection: Program Reporting 

and Performance Standards System for 

Indian and Native American Programs. 

OMB Control Number: 1205–0422. 

Affected Public: Individuals or 

Households; State, Local, and Tribal 

Governments, and Private Sector—notfor-profit institutions. 

Total Estimated Number of 

Respondents: 13,771. 

Total Estimated Number of 

Responses: 28,110. 

Total Estimated Annual Burden 

Hours: 53,611. 

Total Estimated Annual Other Costs 

Burden: $0. 

Dated: May 22, 2013. 

Michel Smyth, 

Departmental Clearance Officer. 

[FR Doc. 2013–12756 Filed 5–29–13; 8:45 am] 

BILLING CODE 4510–FN–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Comment Request for Information 

Collection for ETA Form 232, Domestic 

Agricultural In-Season Wage Report 

and ETA Form 232–A, Wage Survey 

Interview Record, Extension with 

Revisions 

AGENCY: Employment and Training 

Administration (ETA), Labor. 

ACTION: Notice. 

SUMMARY: The Department of Labor 

(Department), as part of its continuing 

effort to reduce paperwork and 

respondent burden, conducts a 

preclearance consultation program to 

provide the public and Federal agencies 

with an opportunity to comment on 

proposed and/or continuing collections 

of information in accordance with the 

Paperwork Reduction Act of 1995 [44 

U.S.C. 3506(c)(2)(A)]. This program 

helps ensure that requested data can be 

provided in the desired format, 

reporting burden (time and financial 

resources) is minimized, collection 

instruments are clearly understood, and 

the impact of collection requirements on 

respondents can be properly assessed. 

Currently, ETA is soliciting comments 

concerning the collection of data about 

ETA Form 232, Domestic Agricultural 

In-Season Wage Report and ETA Form 

232–A, Wage Survey Interview Record, 

OMB Control No. 1205–0017, both of 

which expire July 31, 2013. These forms 

are used by the State Workforce 

Agencies to collect wage information 

from agricultural employers. 

DATES: Written comments must be 

submitted to the office listed in the 


TKELLEY on DSK3SPTVN1PROD with NOTICES